Carmen Gutiérrez-rekin lankidetzan egindako argitalpenak (10)

2011

  1. Dexamethasone upregulates FOXP3 expression without increasing regulatory activity

    Immunobiology, Vol. 216, Núm. 3, pp. 386-392

2010

  1. IL-10 and TNFα genotypes in SLE

    Journal of Biomedicine and Biotechnology, Vol. 2010

2009

  1. Conserved anti-proliferative effect and poor inhibition of TNFα secretion by regulatory CD4+CD25+ T cells in patients with systemic lupus erythematosus

    Clinical Immunology, Vol. 132, Núm. 3, pp. 385-392

2008

  1. IFNα treatment generates antigen-presenting cells insensitive to atorvastatin inhibition of MHC-II expression

    Clinical Immunology, Vol. 129, Núm. 2, pp. 350-359

  2. Influence of functional interleukin 10/tumor necrosis factor-α polymorphisms on interferon-α, IL-10, and regulatory T cell population in patients with systemic lupus erythematosus receiving antimalarial treatment

    Journal of Rheumatology, Vol. 35, Núm. 8, pp. 1559-1566

2006

  1. Cytokine polymorphisms influence treatment outcomes in SLE patients treated with antimalarial drugs

    Arthritis Research and Therapy, Vol. 8, Núm. 2

  2. Enrichment of CD4+ CD25high T cell population in patients with systemic lupus erythematosus treated with glucocorticoids

    Annals of the Rheumatic Diseases, Vol. 65, Núm. 11, pp. 1512-1517

  3. Systemic lupus erythematosus in Asturias, Spain: Clinical and serologic features

    Medicine, Vol. 85, Núm. 3, pp. 157-168

2005

  1. Differential effect of IL10 and TNFα genotypes on determining susceptibility to discoid and systemic lupus erythematosus

    Annals of the Rheumatic Diseases, Vol. 64, Núm. 11, pp. 1605-1610

2003

  1. Epidemiology of systemic lupus erythematosus in a northern Spanish population: Gender and age influence on immunological features

    Lupus, Vol. 12, Núm. 11, pp. 860-865